FCV® and Lower Energy
Prof. Barnes, together with Van Asseldonk and Enk, provide clear theoretical evidence for lower energy dissipation in the lungs by FCV® as compared to VCV or PCV. They present a simple analysis and numerical calculations indicating that energy dissipation may be substantially reduced by controlling the ventilation flow to be constant and continuous during both inspiration and expiration by ventilating at an I:E ratio very close to 1:1 – that is by using FCV®. Read more.
Back to all news items
Eindhoven, 09 March 2022 – The supervisory board of Ventinova Medical is pleased to announce that Hubert Thomassen is the new CEO. Ventinova Medical is a MedTech company that has introduced an innovative and patented ventilation technique that redefines patient...